Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

As politics infects public health, private companies profit

For some counties and cities that share a public health agency with other local governments, differences over mask mandates, business restrictions, and other covid preventive measures have strained those partnerships.

17 Feb 2022

A novel consensus-based computational pipeline that reliably predicts hACE2-RBD binding affinity

Researchers developed a novel computational model to predict the binding affinity between the hACE2 receptor and the RBD of S protein of SARS-CoV-2.

17 Feb 2022

Smartphone-based COVID-19 detection system

In this interview, we speak to Professor Michael Mahan about his latest research which aimed to bring low-cost, state-of-the-art diagnostics to resource-limited settings.

17 Feb 2022

Study looks at COVID-19 vaccine hesitancy in France and Italy

A recent study posted to Research Square* preprint server, and under consideration at the journal Scientific Reports, aimed to learn more about how and to what extent vaccine hesitancy can alter over time at the individual level by considering parameters such as dynamic preferences, news reporting, and gender influence.

16 Feb 2022

Characterization of SARS-CoV-2 variants in unvaccinated and vaccinated U.S. military

Researchers discuss the genomic and virological characterization of SARS-CoV-2 variants among unvaccinated and vaccinated U.S military personnel.

16 Feb 2022

Detection of SARS-CoV-2 RNA by plasmonic-magnetic nanorobots

Researchers present a simple and efficient plasmonic-magnetic nanorobot for the detection of SARS-CoV-2 RNA.

16 Feb 2022

Risk factors for COVID-19 in older adult patients with cancer

Researchers develop a geriatric risk score to predict the risk of severe clinical outcomes in older cancer patients with COVID-19.

16 Feb 2022

Single dose of BNT162b2 vaccine after COVID provides 82% reduction in reinfection risk

Researchers compare the incidence rate of reinfection in convalescent and unvaccinated people to that in recovered and single-dose vaccinated people.

16 Feb 2022

Omicron breakthrough boosts neutralization titers a little more than a 3rd COVID vaccine dose

Researchers compare the neutralizing antibody titers in individuals who received two or three mRNA vaccine doses and experienced breakthrough infections.

16 Feb 2022

Innovative coating kills SARS-CoV-2 and E. coli

Researchers develop a low-cost, non-toxic, and scalable antimicrobial polymer that can be functionalized on diverse fabrics.

16 Feb 2022

SARS-CoV-2 variants are evolving increased infectivity and antibody escape, studies say

First announced by the World Health Organization on Nov. 26, 2021, the SARS-CoV-2 omicron variant spread rapidly around the world, becoming the dominant variant in the U.S. and elsewhere.

16 Feb 2022

Antibodies become more powerful for at least six months after COVID-19 vaccination

For at least six months after COVID-19 vaccination, antibodies produced by immune cells become steadily more formidable and more precisely targeted against the virus that causes COVID-19, according to a study of the antibody response to the Pfizer-BioNTech vaccine by researchers at Washington University School of Medicine in St. Louis.

16 Feb 2022

Study suggests tea polyphenols may modulate COVID-19 via intestinal microbiota

A new study discusses the state of current knowledge about the potential use of tea polyphenols in the prevention and treatment of COVID-19.

16 Feb 2022

Respiratory virus particles likely travel greater distance than previously thought

A modeling study raises questions about how far respiratory droplets, like those that transmit the virus that causes COVID-19, can travel before becoming harmless.

16 Feb 2022

Children with severe COVID-19 show low mucosal neutralizing activity against SARS-CoV-2

A new study examines neutralizing responses to the ancestral variant of SARS-CoV-2, as well as against later variants of concern.

16 Feb 2022

Study confirms that pets can harbor SARS-CoV-2 infection

A new study looks at how dogs and cats within households are susceptible to COVID-19 infection from humans, and whether they act as reservoir species.

16 Feb 2022

Research identifies differences between Omicron lineages BA.1 and BA.2

Researchers recently identified another Omicron lineage, called BA.2, that is more contagious than BA.1, the Omicron lineage that sparked the winter surge of coronavirus cases in January 2022.

16 Feb 2022

COVID-19 related placental tissue destruction and insufficiency may cause stillbirth and neonatal death from hypoxic-ischemic injury

Researchers evaluate the role of the placenta in causing stillbirth and neonatal death post-maternal COVID-19 and confirmed placental positivity for SARS-CoV-2.

16 Feb 2022

Study examines lyophilized mRNA-lipid nanoparticle vaccines with long-term stability

A new study explored the high immunogenicity and stability of lyophilized mRNA-LNP vaccines in relation to SARS-CoV-2.

16 Feb 2022

Impact of Omicron on COVID-19 prevalence among unvaccinated and vaccinated in Omicron-dominated countries

Scientists have recently explored the impact of the omicron variant of SARS-CoV-2 on the prevalence of COVID-19 in vaccinated and unvaccinated individuals.

16 Feb 2022

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

As politics infects public health, private companies profit

A novel consensus-based computational pipeline that reliably predicts hACE2-RBD binding affinity

Smartphone-based COVID-19 detection system

Study looks at COVID-19 vaccine hesitancy in France and Italy

Characterization of SARS-CoV-2 variants in unvaccinated and vaccinated U.S. military

Detection of SARS-CoV-2 RNA by plasmonic-magnetic nanorobots

Risk factors for COVID-19 in older adult patients with cancer

Single dose of BNT162b2 vaccine after COVID provides 82% reduction in reinfection risk

Omicron breakthrough boosts neutralization titers a little more than a 3rd COVID vaccine dose

Innovative coating kills SARS-CoV-2 and E. coli

SARS-CoV-2 variants are evolving increased infectivity and antibody escape, studies say

Antibodies become more powerful for at least six months after COVID-19 vaccination

Study suggests tea polyphenols may modulate COVID-19 via intestinal microbiota

Respiratory virus particles likely travel greater distance than previously thought

Children with severe COVID-19 show low mucosal neutralizing activity against SARS-CoV-2

Study confirms that pets can harbor SARS-CoV-2 infection

Research identifies differences between Omicron lineages BA.1 and BA.2

COVID-19 related placental tissue destruction and insufficiency may cause stillbirth and neonatal death from hypoxic-ischemic injury

Study examines lyophilized mRNA-lipid nanoparticle vaccines with long-term stability

Impact of Omicron on COVID-19 prevalence among unvaccinated and vaccinated in Omicron-dominated countries

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in